Debbie Kanterman joined FKH in 2008. She has approximately 15 years of experience in issues management, advocacy relations, regulatory milestones, media relations, local market campaigns and national celebrity campaigns. Debbie has provided communications counsel supporting a variety of therapeutic areas, including infectious diseases, Alzheimer’s disease, Parkinson’s disease, mental health conditions, men’s health, cardiovascular and metabolic diseases and rare diseases. She has forged strategic partnerships with advocacy organizations to create campaigns that support awareness of conditions that affect small populations to those that affect millions.

Debbie heads up Feinstein Kean’s New Jersey office, located in the heart of the country’s pharmaceutical corridor, where she oversees the team of 12+ professional staff. That team coordinates with colleagues throughout the firm to provide a wide range of services, including product promotion; collaborations with non-profit organizations; launch of policy initiatives; management of co-promoted products; global product launches; support of regulatory milestones for products at all stages of the lifecycle; and issues management, specializing in strategy around advisory committee meetings and label updates.

Debbie received her Bachelor of Science degree in Communications from the S.I. Newhouse School of Public Communications at Syracuse University.